Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using personalized 3D kidney models to improve patient experience before surgery

Official title: Effects of a Personalized or Generic Three-dimensional Tumoral Kidney Model on Patient Experience and Professional-patient Interactions, Before and After Partial Nephrectomy

Run by University Hospital, Bordeaux · NCT06379698 · Data updated 2026-11-12

This study is testing whether using personalized 3D kidney models can help patients feel more informed and less anxious before their kidney surgery compared to using standard models.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment39 (estimated)
SponsorUniversity Hospital, Bordeaux
Academic / other
Locations1 site (Bordeaux)
StatusRecruiting
StartedMay 28, 2024
Main results expectedJune 15, 2027
Study endsJune 15, 2027
Registry record updatedJune 22, 2025
Trial IDNCT06379698 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adult patients scheduled for laparoscopic robotic-assisted partial nephrectomy for unilateral or bilateral kidney tumors.

Probably not a fit

Patients with metastatic disease, previous renal cancers, or those with a single kidney may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to compare the effectiveness of personalized versus generic 3D printed models of patients' tumoral kidneys in enhancing preoperative education and reducing anxiety before nephron-sparing surgery. The study will involve 60 adult patients scheduled for robot-assisted laparoscopic partial nephrectomy, who will be randomized to receive either a personalized or generic 3D model. The primary outcome will be assessed through semi-structured interviews with patients and their caregivers, focusing on their understanding and satisfaction with the surgical process. The trial seeks to address the importance of health literacy and personalized care in improving patient outcomes.

Why it matters

Potential benefit: If successful, this approach could significantly enhance patient understanding and satisfaction, leading to better surgical outcomes and recovery.

How similar studies have gone: Previous pilot studies have shown positive outcomes using personalized 3D-printed models in similar contexts, indicating potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patients:

* Adult patients (≥ 18 years of age)
* Scheduled for surgical management by laparoscopic robotic-assisted partial nephrectomy (1st management for a unilateral or bilateral kidney tumor)
* Expressed consent for integration in the UroCCR database
* Expressed consent for participation in the Rein-3D Personalize study
* Patients affiliated or benefiting from social security system

Professionals:

* Professionals working with patients treated in the Urology, Andrology and Renal Transplant - Department of the Bordeaux University Hospital for at least two months prior to the implementation of 3D models
* Free, informed and signed consent

Exclusion Criteria:

Patients

* Metastatic at inclusion
* Previous renal cancer(s)
* Single kidney at time of inclusion
* No preoperative CT scan, or poor-quality CT scan unable to provide reliable 3D modeling
* Person under legal protection (safeguard of justice, guardianship or curatorship)
* Difficulty understanding and expressing oneself in French

Professionals

* Professionals on internship lasting less than 6 months
* Professionals with no contact with patients

Where it's running

  • CHU de Bordeaux
    Bordeaux, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.